Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron-sulfur cluster co-chaperone protein HscB, mitochondrial (HSCB) is a J-domain co-chaperone of the Hsp40 family that is essential for mitochondrial iron-sulfur (Fe–S) cluster biosynthesis[3][5]. HSCB interacts with the scaffold protein ISCU to facilitate Fe–S cluster transfer within a multiprotein system involving HSPA9 (mortalin/mitochondrial Hsp70) and other biogenesis factors[3][5][1]. Primarily, HSCB mediates protein-protein interactions required for stabilization, maturation, and delivery of Fe–S clusters—which are vital cofactors for respiratory chain complexes and other mitochondrial enzymes[2][5]. Deficiency or mutation in HSCB results in defects in mitochondrial function, leading to diseases such as sideroblastic anemia and potentially neurodegenerative conditions linked to impaired iron metabolism[3][6]. There are currently no approved drugs targeting HSCB directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-sulfur cluster co-chaperone protein HscB, mitochondrial (HSCB).